Stratos Wealth Partners, Ltd. Crispr Therapeutics Ag Transaction History

Stratos Wealth Partners, Ltd.

$6.79 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$51.17 - $68.18 $21,082 - $28,090	-412 Reduced 8.33%	4,536 $244,000
Q1 2024 Apr 16, 2024	SELL	$60.67 - $89.12 $88,092 - $129,402	-1,452 Reduced 22.69%	4,948 $337,000
Q4 2023 Jan 24, 2024	BUY	$38.62 - $72.18 $31,668 - $59,187	820 Added 14.7%	6,400 $400,000
Q3 2023 Oct 24, 2023	BUY	$45.39 - $59.0 $55,648 - $72,334	1,226 Added 28.16%	5,580 $253,000
Q2 2023 Jul 18, 2023	BUY	$43.47 - $67.77 $189,268 - $295,070	4,354 New	4,354 $244,000
Q3 2022 Oct 24, 2022	SELL	$61.1 - $83.78 $10,203 - $13,991	-167 Reduced 4.23%	3,784 $247,000
Q2 2022 Jul 22, 2022	SELL	$43.23 - $73.83 $1,772 - $3,027	-41 Reduced 1.03%	3,951 $240,000
Q1 2022 Apr 26, 2022	BUY	$53.19 - $79.24 $11,223 - $16,719	211 Added 5.58%	3,992 $251,000
Q4 2021 Jan 14, 2022	BUY	$70.09 - $111.29 $14,018 - $22,258	200 Added 5.59%	3,781 $287,000
Q3 2021 Oct 19, 2021	BUY	$110.2 - $156.64 $10,469 - $14,880	95 Added 2.73%	3,581 $401,000
Q2 2021 Jul 19, 2021	SELL	$100.84 - $161.89 $65,747 - $105,552	-652 Reduced 15.76%	3,486 $564,000
Q1 2021 Apr 27, 2021	SELL	$110.72 - $210.04 $7,418 - $14,072	-67 Reduced 1.59%	4,138 $504,000
Q4 2020 Jan 29, 2021	BUY	$79.67 - $173.23 $53,378 - $116,064	670 Added 18.95%	4,205 $644,000
Q3 2020 Oct 29, 2020	SELL	$78.5 - $100.64 $56,520 - $72,460	-720 Reduced 16.92%	3,535 $296,000
Q2 2020 Jul 28, 2020	BUY	$38.5 - $76.05 $163,817 - $323,592	4,255 New	4,255 $313,000
Q1 2020 May 04, 2020	SELL	$33.68 - $62.53 $123,268 - $228,859	-3,660 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$36.68 - $73.13 $134,248 - $267,655	3,660 New	3,660 $223,000
Q4 2018 Feb 08, 2019	SELL	$22.73 - $42.34 $35,686 - $66,473	-1,570 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$44.35 - $65.71 $69,629 - $103,164	1,570 New	1,570 $70,000
Q2 2018 Aug 13, 2018	SELL	$42.62 - $73.59 $19,818 - $34,219	-465 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$23.52 - $58.17 $10,936 - $27,049	465 New	465 $21,000

Others Institutions Holding CRSP

# of Institutions

486

Shares Held

57.9M

Call Options Held

1.09M

Put Options Held

1.9M

Capital International Investors Los Angeles, CA

7.93M
Shares

$344 Million
0.07% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.5M
Shares

$326 Million
3.35% of portfolio
State Street Corp Boston, MA

2.99M
Shares

$130 Million
0.01% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.97M
Shares

$129 Million
0.1% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$129 Million
1.61% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.39B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.

Account